CELECOXIB News
CELECOXIB currently has 0 news articles, with 19 predicted indications.
This page combines the AI-predicted indications for CELECOXIB with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (19):
- ankylosing spondylitis (99.0%)
- juvenile arthritis due to defect in LACC1 (99.0%)
- spondyloarthropathy, susceptibility to (99.0%)
- arthropathy (99.0%)
- rheumatoid arthritis (99.0%)
- osteoarthritis susceptibility (99.0%)
- spondyloarthropathy (99.0%)
- juvenile idiopathic arthritis (99.0%)
- osteoarthritis (99.0%)
- acromesomelic dysplasia, Hunter-Thompson type (99.9%)
- brachyolmia-amelogenesis imperfecta syndrome (99.9%)
- rheumatoid vasculitis (99.8%)
- myosclerosis (99.8%)
- hypermobility of coccyx (99.8%)
- brachyolmia (99.8%)
- rheumatoid nodulosis (99.8%)
- rheumatoid factor-positive polyarticular juvenile idiopathic arthritis (99.8%)
- inflammatory spondylopathy (99.8%)
- WHIM syndrome (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.